Borotommo
Well-known member
Ventilator bed occupation down to 312 on 22nd Feb. Almost half the figure from 1 month ago!
Effectively after vaccination 1 and 2, the graphs (showing antibodies) dipped a lot in the over 50's (showing waning of immunity from vaccination/ infection over time). This time the booster/ infection is maintaining antibodies, and if anything, they're increasing.I looked at the graphs Andy and I didn't really understand what they were saying. Do I need to read the whole thread for context?
In other news, and you may have seen this, a uni in Japan are working on a one and done vaccine for Covid which is going well and expected to be ready next year. I read this about 3 or 4 months ago.
That would be the ideal solution.
Thats what I read into the graphs. Unfortunately I read something that is at odds with that analysis. I'll see if I can find it again and post. With a 3rd jab efficacy, according to that report, waned to 40% at preventing serious disease after 10 weeks.Effectively after vaccination 1 and 2, the graphs (showing antibodies) dipped a lot in the over 50's (showing waning of immunity from vaccination/ infection over time). This time the booster/ infection is maintaining antibodies, and if anything, they're increasing.
Effectively it proves that with each vaccination/ infection that protection goes higher, and lasts a lot longer than the previous jab/ infection did, but this was expected as some of the immunologists were mentioning it months ago. I posted the expected graphs at the time too, looks bang on. Basically is quashes the comments saying we will need multiple boosters.
Basically there's no evidence that the majority of the population would need a 4th jab, and also at this stage it seems unlikely the oldies need it too (albeit they might still get offered one).
I would think of a "one dose" vaccine more like an omicron specific vaccine, which would also cover Delta, Alpha, Beta etc (knowledge has improved greatly in two years), but there is no guarantee it wouldn't need boosting, just like J&J was meant to be one dose. May as well just stick with AZ or anything that can be made quickly, and then boost it with Pfizer or an adapted Pfizer.
By the time a new one dose vaccine goes through approval and testing, and proven to have no waning Omicron will have got to everyone. I bet they actually struggle to find people who haven't already been vaccinated or had it, and it's not like the anti vaxers are going to jump on it. The only places with low vax uptake are places which are poor and have very poor monitoring etc, hard to do trials like we did back in 2020 when there was loads of unexposed people to go at.
Hopefully Billy this thread will end shortly.
When it does thanks for your inputs it was appreciated. I would love to be able to thank bear too.
Nah it's not, my graphs were showing antibodies, those graphs in your report show protection against varying degrees of severity.Thats what I read into the graphs. Unfortunately I read something that is at odds with that analysis. I'll see if I can find it again and post. With a 3rd jab efficacy, according to that report, waned to 40% at preventing serious disease after 10 weeks.
Log date:2 March 2022
Log category: DATA ISSUE
Deaths figures for England incomplete
Due to a technical issue affecting one route of reporting to UKHSA, the number of COVID-19 deaths may be lower than otherwise expected. This is anticipated to be a temporary limitation, and any delayed reporting will be resolved in the coming days.